Oscar Health: Scale Is Finally Showing Up On The Bottom-Line
Oscar Health's shares have more than doubled since April, yet the stock trades at a forward price‑to‑sales ratio of about 0.50, indicating significant undervaluation. The company continues to post revenue growth, expanding margins, and accelerating earnings. The analyst maintains a Buy rating despite elevated short interest reflecting market skepticism.
- ▪Oscar Health shares have risen over 100% since April.
- ▪The stock trades at a forward price‑to‑sales ratio of roughly 0.50, suggesting more than 80% undervaluation versus the sector median.
- ▪Revenue growth, margin expansion, and accelerating bottom‑line performance underpin the analyst's Buy rating.
- ▪Short interest in Oscar Health is elevated, indicating market skepticism.
- ▪The article was published on July 24, 2026.
Seeking Alpha files mainly under finance. We currently carry 6,336 of its stories.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Stock Ideas","item":"https://seekingalpha.com/stock-ideas"},{"@type":"ListItem","position":3,"name":"Long Ideas","item":"https://seekingalpha.com/stock-ideas/long-ideas"},{"@type":"ListItem","position":4,"name":"Financials ","item":"https://seekingalpha.com/stock-ideas/financial"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4925523-oscar-health-scale-is-finally-showing-up-on-the-bottom-line"},"author":{"@type":"Person","name":"The J…
Excerpt limited to ~120 words for fair-use compliance. The full article is at All Articles on Seeking Alpha.
Discussion
0 commentsMore from All Articles on Seeking Alpha
